若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

STEMprep™ 组织处理器

使用 STEMprep™ 实现组织自动解离,可靠获得高得率、高活率的单细胞悬液,助力您的科研工作

产品号 #(选择产品)

产品号 #100-2112_C

使用 STEMprep™ 4个样本量系统自动化组织解离,获得高得率、高活率的单细胞悬液

产品优势

  • 标准化组织解离流程,实现一致且可重复的结果
  • 获得大量具有高活率和功能性的单细胞
  • 通过4°C-37°C的灵活温度控制系统保证最佳处理条件
  • 可根据需求安装拓展模块以同时处理4、 8、12个样本
  • 可使用STEMCELL的优化方案或根据不同的组织类型和需求创建您自己的定制化方案

产品组分包括

  • STEMprep™ 组织处理器 4 样本系统(产品号 #100-2112)
    • STEMprep™ 组织处理器主机
    • 离心管塑料架
  • STEMprep™ 组织处理器 8 样本系统(产品号 #100-2114)
    • STEMprep™ 组织处理器主机
    • STEMprep™ 组织处理器扩展模块
    • 离心管塑料架
  • STEMprep™ 组织处理器 12 样本系统(产品号 #100-2115)
    • STEMprep™ 组织处理器主机
    • 2 个 STEMprep™ 组织处理器扩展模块
    • 离心管塑料架
  • STEMprep™ 组织处理器 4 样本扩展模块(产品号 #100-2113)
    • STEMprep™ 组织处理器扩展模块
    • 离心管塑料架

What Our Scientist Says

Tissue processing doesn't need to be complex and time consuming. STEMprep™ takes the hassle out of sample prep with a sleek, customizable interface and built-in temperature control to keep your samples cool and your workflow smooth. Less time prepping, more time generating data that you trust—that’s the power of STEMprep™.

Grace Poon, PhDSenior Scientist
Grace Poon, Senior Scientist

总览

使用STEMprep™组织处理器实现组织解离的自动化与标准化。这款模块化系统旨在生成高得率、高活率的单细胞悬液,同时有效保持表位完整性与细胞功能。 STEMprep™ 通过直观的触摸屏界面简化方案选择与设置,优化工作流程,显著提升工作效率并降低人为操作误差。系统内置4°C至37°C的精准温控功能,确保各种样本类型和应用都能在最佳处理条件下进行,无需额外配置冷却或加热装置。无论您选择使用经过验证的STEMCELL标准方案,还是自定义实验方案,STEMprep™都能灵活适配不同组织类型和实验需求。 该系统可与STEMprep™样本管及组织特异性STEMprep™解离试剂盒无缝配合使用,确保在不同应用中实现高效的样本处理和一致的组织解离效果。 这款模块化台式平台具备可扩展性,能满足日益增长的通量需求。系统以主单元(包含触屏界面)为基础,可通过添加扩展模块(每个可额外处理4个样本)不断提升通量。 系统基础配置为4个样本量处理能力,包含1个主单元和1个离心管塑料架。若需处理更多样本,可添加扩展模块——每增加一个模块可增加4个样本的处理量。8个样本量系统包含1个主单元和1个扩展模块,12个样本量系统则包含2个扩展模块。所有配置均标配离心管塑料架。如需处理超过12个样本,可通过添加扩展模块实现每次增加4个样本量的处理能力。 欲了解更多关于 STEMprep™ 的信息,请访问STEMprep™概述页面。您也可以查看我们的仪器概览页面,或下载仪器服务手册了解保修范围及其他服务方案。

应用
Sample Preparation
 
品牌
STEMprep
 
研究领域
癌症, 免疫, 感染性疾病(传染病)
 

Data Figures

STEMprep™ Tissue Dissociation Workflow

Figure 1. STEMprep™ Tissue Dissociation Workflow

The STEMprep™ Tissue Dissociator enables efficient processing of a wide range of tissues, including mouse brain, liver, lung, spleen, and tumors. In this workflow, tissue samples are placed into a STEMprep™ Sample Tube and processed using the STEMprep™ Tissue Dissociator in combination with the appropriate STEMprep™ Tissue Dissociation Kit. Depending on the selected protocol-dissociation or homogenization-the resulting output is either a single-cell suspension or a sample suitable for nucleic acid isolation. STEMprep™-processed cells are compatible with downstream applications such as cell separation, cell culture, flow cytometry, and other assays.

STEMprep™ Cold Temperature Hold Feature Preserves Mouse Lung and Spleen Cell Viability

Figure 2. STEMprep™ Cold Temperature Hold Feature Preserves Mouse Lung and Spleen Cell Viability

Mouse lung and spleen tissues were dissociated using the STEMprep™ Mouse Lung and Spleen Dissociation Kits, respectively. After the protocol run was completed, the samples were held on the STEMprep™ Tissue Dissociator for up to 24 hours at 4°C, 22°C, and 37°C. Viability of total nucleated (A) lung and (B) spleen cells. Data are presented as mean ± SD (n = 3).

RNA Yields from Tissues Homogenized Using the STEMprep™ Tissue Dissociator Are Comparable to Other Common Homogenization Methods

Figure 3. RNA Yields from Tissues Homogenized Using the STEMprep™ Tissue Dissociator Are Comparable to Other Common Homogenization Methods.

Mouse (A) brain, (B) lung, or (C) liver tissues were homogenized using the STEMprep™ Tissue Dissociator or an alternative automated system. RNA was subsequently extracted using the EasySep™ Total Nucleic Acid Extraction Kit (with DNase I treatment). The yield of RNA per mg of tissue was assessed using the Qubit Flex Instrument and Qubit RNA Broad Range Assay kit. Data are presented as mean ± SD (n = 8).

STEMprep™ Direct Tissue Homogenization Yields High-Quality RNA

Figure 4. STEMprep™ Direct Tissue Homogenization Yields High-Quality RNA

RNA integrity number (RIN) of RNA extracted from mouse (A) brain, (B) lung, or (C) liver tissues. Tissues were homogenized using the STEMprep™ Tissue Dissociator or an alternative automated system. RNA was subsequently extracted from the resulting homogenates by EasySep™ Total Nucleic Acid Extraction Kit (with DNase I treatment). The quality of the extracted RNA was assessed using the 2100 Bioanalyzer Instrument and Agilent RNA 6000 Nano Kit. Data are presented as mean ± SD (n = 8).

STEMprep™ Template Protocol Information

Figure 5. STEMprep™ Template Protocol Information

Step 1 (Prime): A brief slow spin during pre-heat.

Steps 2 and 3 (Cut): Steps 2 and 3 are looped with a repeat count of 2. A reverse spin (-40 RPM) is applied to step 3 to ensure free movement of tissue.

Note: Reduce speed for soft tissues. Increase speed or number of loops for hard tissues.

Step 4 (Incubate): Slow spin to agitate tissue during incubation with enzyme cocktail.

Step 5 (Dissociate): High-speed spin to generate single cells.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Quick Start Guide
Catalog #
100-2112
Lot #
All
Language
English
Catalog #
100-2112
Lot #
All
Language
English
Document Type
Technical Manual
Catalog #
100-2112
Lot #
All
Language
English

Resources and Publications

Educational Materials (6)

Publications (1)

Microbial dysbiosis sculpts a systemic ILC3/IL-17 axis governing lung inflammatory responses A Kabil et al. Mucosal Immunology 2025 July

Abstract

Advancements in vaccination and sanitation have significantly reduced the prevalence and burden of infectious diseases; however, these benefits have coincided with a marked rise in autoimmune and allergic disorders. Recent studies have investigated these linked trends through the lens of host-microbiome alterations, proposing these shifts as a potential explanatory mechanism. Previously, we demonstrated that vancomycin-induced depletion of short-chain fatty acid (SCFA)-producing bacteria results in hyperactivation of ILC2s and exacerbated allergic responses. Here we investigate the effects of low-dose streptomycin on innate and adaptive immune cell populations and their activation states. Although streptomycin-treated mice exhibit normal allergic responses, they display heightened susceptibility to Th1/Th17-mediated disease, specifically hypersensitivity pneumonitis (HP). This is characterized by a two-fold increase in ILC3s and Th17 cells in the lungs, alongside activation of antigen-presenting cells (APCs) at steady state-an effect that is further amplified upon exposure to HP-inducing agents. Shotgun metagenomic analysis revealed that streptomycin-induced dysbiosis reduces microbial diversity, depletes bile acid-metabolizing bacteria, and enriches for metabolic pathways involved in branched-chain amino acid biosynthesis, including leucine-a known activator of mTORC1. Strikingly, administration of the secondary bile acid metabolite isolithocholic acid (an inverse agonist of RORγt), or an IL-23 neutralizing antibody, reverses the enhanced susceptibility to HP. Inhibition of mTORC1 significantly reduced Th17/ILC3 responses and histopathology. Our findings underscore microbial equilibrium as a key determinant of susceptibility to HP and uncover a positive feedback loop between IL and 23-producing APCs and ILC3/Th17 cells that mechanistically links dysbiosis to sustained type 3 inflammation, and we identify a simple, actionable means of intervention.
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.